177 related articles for article (PubMed ID: 34202375)
1. Identifying Circulating MicroRNA in Kawasaki Disease by Next-Generation Sequencing Approach.
Weng KP; Cheng CF; Chien KJ; Ger LP; Huang SH; Tsai KW
Curr Issues Mol Biol; 2021 Jun; 43(2):485-500. PubMed ID: 34202375
[TBL] [Abstract][Full Text] [Related]
2. Association between serum miR-221-3p and intravenous immunoglobulin resistance in children with Kawasaki disease.
Jing F; Weng H; Pei Q; Zhang J; Liu R; Yi Q
Clin Exp Med; 2022 Nov; 22(4):621-628. PubMed ID: 35039938
[TBL] [Abstract][Full Text] [Related]
3. Serum miR-92a-3p as a New Potential Biomarker for Diagnosis of Kawasaki Disease with Coronary Artery Lesions.
Rong X; Jia L; Hong L; Pan L; Xue X; Zhang C; Lu J; Jin Z; Qiu H; Wu R; Chu M
J Cardiovasc Transl Res; 2017 Feb; 10(1):1-8. PubMed ID: 27981487
[TBL] [Abstract][Full Text] [Related]
4. Serum exosomal microRNA let-7i-3p as candidate diagnostic biomarker for Kawasaki disease patients with coronary artery aneurysm.
Wang YF; Lian XL; Zhong JY; Su SX; Xu YF; Xie XF; Wang ZP; Li W; Zhang L; Che D; Yu L; Huang P; Jia HL; Gu XQ
IUBMB Life; 2019 Jul; 71(7):891-900. PubMed ID: 30724444
[TBL] [Abstract][Full Text] [Related]
5. The Platelet microRNA Profile of Kawasaki Disease: Identification of Novel Diagnostic Biomarkers.
Ning Q; Chen L; Song S; Zhang H; Xu K; Liu J; Zhou Y; Zang C; Li G; Chen F; Jia J; Ding G; Huang M
Biomed Res Int; 2020; 2020():9061568. PubMed ID: 32733962
[TBL] [Abstract][Full Text] [Related]
6. Circulating MicroRNAs as Potential Molecular Biomarkers for Intracranial Aneurysmal Rupture.
Supriya M; Christopher R; Indira Devi B; Bhat DI; Shukla D
Mol Diagn Ther; 2020 Jun; 24(3):351-364. PubMed ID: 32323261
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Significance of miR-937 in Peripheral Blood Mononuclear Cells of Kawasaki Disease.
Wang Z; Zhou J; Dong N; Li W
Clin Lab; 2019 Nov; 65(11):. PubMed ID: 31710429
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs differentiate Kawasaki Disease from infectious febrile illnesses in childhood.
Jone PN; Korst A; Karimpour-Fard A; Thomas T; Dominguez SR; Heizer H; Anderson MS; Glode MP; Sucharov CC; Miyamoto SD
J Mol Cell Cardiol; 2020 Sep; 146():12-18. PubMed ID: 32634388
[TBL] [Abstract][Full Text] [Related]
9. Circulating microRNAs as potential biomarkers for the identification of vascular dementia due to cerebral small vessel disease.
Prabhakar P; Chandra SR; Christopher R
Age Ageing; 2017 Sep; 46(5):861-864. PubMed ID: 28633305
[TBL] [Abstract][Full Text] [Related]
10. miR-941 as a promising biomarker for acute coronary syndrome.
Bai R; Yang Q; Xi R; Li L; Shi D; Chen K
BMC Cardiovasc Disord; 2017 Aug; 17(1):227. PubMed ID: 28830367
[TBL] [Abstract][Full Text] [Related]
11. Global and targeted circulating microRNA profiling of colorectal adenoma and colorectal cancer.
Zhang J; Raju GS; Chang DW; Lin SH; Chen Z; Wu X
Cancer; 2018 Feb; 124(4):785-796. PubMed ID: 29112225
[TBL] [Abstract][Full Text] [Related]
12. Plasma microRNA Profiles as a Potential Biomarker in Differentiating Adult-Onset Still's Disease From Sepsis.
Hu Q; Gong W; Gu J; Geng G; Li T; Tian R; Yang Z; Zhang H; Shao L; Liu T; Wan L; Jia J; Yang C; Shi Y; Shi H
Front Immunol; 2018; 9():3099. PubMed ID: 30687316
[TBL] [Abstract][Full Text] [Related]
13. Identification of non-invasive biomarkers for chronic atrophic gastritis from serum exosomal microRNAs.
Liu H; Li PW; Yang WQ; Mi H; Pan JL; Huang YC; Hou ZK; Hou QK; Luo Q; Liu FB
BMC Cancer; 2019 Feb; 19(1):129. PubMed ID: 30736753
[TBL] [Abstract][Full Text] [Related]
14. A plasma mir-125a-5p as a novel biomarker for Kawasaki disease and induces apoptosis in HUVECs.
Li Z; Jiang J; Tian L; Li X; Chen J; Li S; Li C; Yang Z
PLoS One; 2017; 12(5):e0175407. PubMed ID: 28467514
[TBL] [Abstract][Full Text] [Related]
15. Sets of serum exosomal microRNAs as candidate diagnostic biomarkers for Kawasaki disease.
Jia HL; Liu CW; Zhang L; Xu WJ; Gao XJ; Bai J; Xu YF; Xu MG; Zhang G
Sci Rep; 2017 Mar; 7():44706. PubMed ID: 28317854
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-197-3p mediates damage to human coronary artery endothelial cells via targeting TIMP3 in Kawasaki disease.
Liu C; Yang D; Wang H; Hu S; Xie X; Zhang L; Jia H; Qi Q
Mol Cell Biochem; 2021 Dec; 476(12):4245-4263. PubMed ID: 34351574
[TBL] [Abstract][Full Text] [Related]
17. The expression and significance of serum caveolin-1 in patients with Kawasaki disease.
Zhu F; Huang J; Wang X; Li P; Yan Y; Zheng Y; He Y; Wu T; Ren Y; Wu R
Chin J Physiol; 2020; 63(2):90-94. PubMed ID: 32341235
[TBL] [Abstract][Full Text] [Related]
18. Identification of Circulating MicroRNAs in Biliary Atresia by Next-Generation Sequencing.
Peng X; Yang L; Liu H; Pang S; Chen Y; Fu J; Chen Y; Wen Z; Zhang R; Zhu B; Yu J; Invernizzi P
J Pediatr Gastroenterol Nutr; 2016 Nov; 63(5):518-523. PubMed ID: 26960174
[TBL] [Abstract][Full Text] [Related]
19. Genetic variants of ADAM17 are implicated in the pathological process of Kawasaki disease and secondary coronary artery lesions via the TGF-β/SMAD3 signaling pathway.
Peng Q; Deng Y; Yang X; Leng X; Yang Y; Liu H
Eur J Pediatr; 2016 May; 175(5):705-13. PubMed ID: 26833052
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic significance of circulating miRNAs in Kawasaki disease in China: Current evidence based on a meta-analysis.
Zheng X; Li Y; Yue P; Ma F; Zhang Y; Wu G
Medicine (Baltimore); 2021 Feb; 100(6):e24174. PubMed ID: 33578520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
